Skip to main content
SpringerLink
Log in

A “relatively small” proportion of patients on generic levetiracetam required switch-back to the branded drug,

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Chaluvadi S, Tran L, Goldsmith C, Friedman D.Clinical experience with generic levetiracetam in a tertiary care epilepsy clinic. 62nd Annual Meeting of the American Academy of Neurology: abstr. P05.176, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

A “relatively small” proportion of patients on generic levetiracetam required switch-back to the branded drug,. React. Wkly. 1300, 2 (2010). https://doi.org/10.2165/00128415-201013000-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013000-00002

Keywords

Search

Navigation